Dietary effects on cardiac metabolic properties in rodents.
Previous studies have shown that dietary provision of carbohydrate can alter cardiac isomyosin distribution in hormonally deficient rats. The main objective of this study was to determine if varying the heart's potential to utilize carbohydrate for energy provision can influence the cardiac isomyosin expression in normal weanling rats. Animals were assigned to one of five groups according to dietary and/or metabolic treatment: (1) mixed-control--(M); (2) high carbohydrate--(H); (3) low carbohydrate--(L); (4) mixed-diet supplemented with oxfenicine, a cardiospecific fatty acid oxidation inhibitor--(MO); and (5) high carbohydrate diet supplemented with oxfenicine--(HO). The results show that 4 weeks of dietary manipulations aimed to either increase or decrease carbohydrate supply to the heart, failed to induce any alterations in either cardiac myosin ATPase activity or isoenzyme pattern. However, extremes in carbohydrate provision altered the metabolic properties of both heart and skeletal muscle. A low carbohydrate diet increased 3-hydroxyacyl CoA dehydrogenase (P less than 0.05) and citrate synthase activities (P less than 0.05) and decreased glycogen content in both heart and soleus muscle; whereas, a high carbohydrate diet, in conjunction with oxfenicine, tended to increase hexokinase activity in these same tissues. These alterations provide indirect evidence that the contributions of both fat and carbohydrate to the energy balance of the heart and skeletal muscle were altered by the imposed dietary interventions. Collectively, these results suggest that although the substrate utilization patterns of the normal weanling heart can be modified via dietary manipulation, such shifts do not exert any regulatory influence on cardiac isomyosin expression.
Haddad
F
F
Department of Physiology and Biophysics, University of California Irvine 92717.
Baldwin
K M
KM
Morris
G S
GS
D000251:Adenosine Triphosphatases / Q000378:metabolism; D000818:Animals; D015415:Biomarkers / Q000032:analysis; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight; D050260:Carbohydrate Metabolism; D002241:Carbohydrates / Q000494:pharmacology* / Q000502:physiology; D004032:Diet; D004734:Energy Metabolism; D005227:Fatty Acids / Q000378:metabolism; D005260:Female; D006003:Glycogen / Q000032:analysis / Q000097:blood; D006321:Heart / Q000033:anatomy & histology / Q000187:drug effects; D007527:Isoenzymes / Q000378:metabolism; D008099:Liver / Q000032:analysis; D009132:Muscles / Q000032:analysis; D009206:Myocardium / Q000032:analysis / Q000378:metabolism*; D009210:Myofibrils / Q000201:enzymology; D009218:Myosins / Q000378:metabolism; D009929:Organ Size; D051381:Rats; D011919:Rats, Inbred Strains
D015415:Biomarkers; D001786:Blood Glucose; D002241:Carbohydrates; D005227:Fatty Acids; D007527:Isoenzymes; D006003:Glycogen; D000251:Adenosine Triphosphatases; D009218:Myosins